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Intracellular microrheologyRecently, the structure–function relationships between amphotericin B (AmB) and ergosterol have been
solved using synthetic techniques that require a mycosamine-mediated direct binding interaction between
AmB and ergosterol to form AmB ion channels. However, studies to directly probe the AmB-induced mem-
brane permeability changes have not been conducted. In the present work, we investigate the following
fundamental question: does AmB induce concentration- and time-dependent permeability changes across
ergosterol-containing membranes? Herein, we employ ﬂuorescent dyes of known average diameter to
quantify the diameters of AmB ion channels. In addition, we take a single-particle tracking approach to de-
ﬁne the intracellular microrheology in the absence and presence of AmB ion channels. Present results show
that increasing AmB concentration tends to increase the preferential accumulation of AmB ion channels in
the presence of the excess membrane-embedded ergosterol. We found that AmB induces time-dependent
membrane permeability; increases approaching 50% in both the velocity ﬂuctuations and diffusion coefﬁ-
cients of vesicles occur on the same time scale as the efﬂux of potassium ions (≅30 min). Furthermore,
we propose a two-dimensional, semi-regular tessellation model to geometrically assess the pore size of
the AmB ion channels in response to the AmB dose. This approach offers one possibility for the design of
AmB ion channels with tunable aqueous pore size, which could provide an opportunity to replace damaged
membrane water channels of the aquaporin family in future applications.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The polyene antibiotic amphotericin B (AmB) has been considered
the standard in antifungal therapy for deep-seated systemic fungal
infections since its release in the 1950s [1–3]. The antifungal activity
of AmB is most closely related to its ability to form hydrophilic aqueous
pores via binding to ergosterol in the fungal cell membrane. Pore forma-
tion not only promotes plasmamembrane destabilization but also allows
for the leakage of intracellular components such as potassium ions,
which are responsible for cell lysis. This process ultimately results in
rapid cell death [4,5]. AmB has also been reported to have a substantially
higher afﬁnity for ergosterol than cholesterol [6,7]. Speciﬁcally, AmB in-
teracts more rapidly with fungal cells than human cells [8]. The substitu-
tion of cholesterol with ergosterol in tumor cells has thus been proposed
as a possible opportunity for anticancer therapy [9,10].gy, Taipei Medical University,
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l rights reserved.The binding paradigm for the interaction between AmB and ergos-
terol has been determined by nuclearmagnetic resonance spectroscopy
[6]; the aqueous pores consist of an annulus of eight AmB molecules
that are hydrophobically linked to eight ergosterol molecules [11–15].
In addition, the eight subunits that make up the aqueous pore are
arranged as the staves of a barrel, with their hydrophilic sides forming
a central channel approximately 8 Å in diameter [11,14]. Recently, the
structure–function relationships between AmB and ergosterol have
been solved using a synthetic technique based on the synthesisenabled
deletion of functional groups from the polyenemacrolide skeleton. This
technique reveals key underpinnings of amphotericin B ion channel and
antifungal activities. Speciﬁcally, a mycosamine-mediated direct bind-
ing interaction between AmB and ergosterol is required to both form
ion channels and kill yeast cells [16,17]. A voltage clamp planar lipid
bilayer system has also been used to probe the formation of discrete
ion channels and investigate the membrane-permeabilizing activity of
AmB [16]. However, studies to directly probe the real-time changes in
the intracellular responses of living cells caused by the presence of
AmB ion channels have not been conducted.
1795T.-S. Yang et al. / Biochimica et Biophysica Acta 1828 (2013) 1794–1801Recently, it has been recognized that the extract of Taiwanofungus
camphoratus possesses extensive biological activity, such as
hepatoprotective, antihypertensive, anti-hyperlipidemic, immuno-
modulatory, antioxidant, anti-inﬂammatory and anticancer proper-
ties [18–20]. In our preliminary experiments, we found that treating
cancer cells with the ethanolic extract of T. camphoratus might
increase the susceptibility of the plasma membrane of cancer cells
to AmB [21]. In addition, pretreatment with the ethanolic extract of
T. camphoratus followed by AmB treatment dramatically inhibited cell
proliferation in HT29 cells. This result implies that cholesterol, the
dominant sterol in mammalian cell membranes, was substituted with
ergosterol. This effect can be attributed to the presence of ergosterol
in the ethanolic extract of T. camphoratus [18].
In this study, we also apply the organic solvent n-hexane to ex-
tract solid state cultivated T. camphoratus. The main purpose of this
study is to provide direct evidence to prove whether pretreatment
with T. camphoratus n-hexane extract (TCHE) followed by AmB treat-
ment leads to a change in the cell-membrane permeability. In addition,
we propose a new cell membrane permeabilization method for the de-
tection of intracellular microrheology in the absence and presence of
AmB ion channels. Furthermore, we hypothesize that increasing AmB
concentrations tend to increase the preferential accumulation of AmB
ion channels; this consequence can be explained by our semi-regular
tessellationmodel. Finally, conclusions are offered, and areas for further
study are identiﬁed.
2. Materials and methods
2.1. AmB and TCHE preparation
The AmB was purchased from Sigma Aldrich Co. (St. Louis, MO). A
pulverized crude extract of solid state cultivated T. camphoratus was
provided by Well Shine Biotechnology Development (Taipei, Taiwan)
and prepared as previously described; the resulting compound
contained 15–20% triterpenoids and 1–2% polysaccharides [21]. In this
study, we used the organic solvent n-hexane to extract solid-state culti-
vated T. camphoratus. The resultant extract proved to be more effective
than ethanolic extract in preventing the proliferation of HT29 cells. In
addition, the n-hexane extract of T. camphoratus was separated by
preparative thin layer chromatography (TLC) with Kiesel gel
60 F254 (Merck), as shown in Fig. S1. One fraction (# 8) in panel
(A) was found to be active in synergistic to AmB, where the stationary
phase was silica gel and the mobile phase was CHCl3. This fraction
could be further separated using the TLC silica gel plate developed in a
mixture of CHCl3–MeOH (98:2 v/v), as shown in Fig. S1(B). Here the
separated extract (# 8) in panel (B), denoted as TCHE in this study,
was scratched and subjected to further puriﬁcation.We found that pre-
treatment with TCHE followed by AmB treatment remarkably and dra-
matically inhibited the proliferation of HT29 cells.
2.2. Cell culture and drug treatments
The human colon cancer cell line HT29 was purchased from the
Food Industry Research and Development Institute (FIRDI) (Hsinchu,
Taiwan, Republic of China) and cultured up to ≈60% conﬂuence in
Dulbecco's Modiﬁed Eagle Medium (DMEM) supplemented with 10%
heat-inactivated fetal bovine serum (FBS), 100 IU/ml penicillin, and
100 mg/ml streptomycin (Gibco, Grand Island, NY) under standard cul-
ture conditions (37 °C, 95% humidiﬁed air and 5% CO2). The HT29 cells
were trypsinized, counted and resuspended at the appropriate density
(≈2 × 105 cells/ml) in fresh culture medium. These HT29 cells were
then seeded onto collagen-1-coated glass coverslips for 3 h at 37 °C.
Next the cells were pretreated with 10 μg/ml of TCHE for 21 h at
37 °C followed by a further incubationwith AmB at different concentra-
tions ranged from 40 pg/ml to 6 μg/ml for 1 h at 37 °C.To distinguish the cell-membrane permeability and quantify the
pore size of the AmB ion channels, both Alexa Fluor® 635 phalloidin
(Molecular Probes) and quantum dot conjugated to epidermal growth
factor (QD-EGF, Molecular Probes) were used. Alexa Fluor® 633
phalloidin molecule, a high-afﬁnity F-actin probe, is optimal for ﬁxed
and permeabilized cultured cells. Because the sizes of the phalloidin
and Alexa Fluor molecules are ≅6 Å [22] and ≅10 Å [23], respectively;
therefore, HT29 cells were treated with Alexa Fluor® 635 phalloidin
(≅16 Å) at 37 °C for 30 min to assess the blocking effect andmembrane
permeability of AmB ion channels at lower AmB concentrations. HT29
cells were also incubated with QD-EGF at 4 °C and ﬁxed in 4% para-
formaldehyde (PFA) to eliminate the possibility of epidermal growth
factor receptor (EGFR)-mediated internalization because HT29 cells
expressed relatively high levels of EGFR [24]. Similarly, QD-EGF
(≅120–160 Å) [25] can be used to determine the pore diameter of
AmB ion channels at higher AmB concentrations.
2.3. The specially designed ﬂow cell
We have designed a ﬂow cell system assembled by placing one
layer of paraﬁlm (100 μmthick) cut in chamber shape between amicro-
scope glass slide and a collagen-1-coated coverglass (170 μm thick).
Two holes drilled through glass slide form the entrance and exit ports
for the ﬂow cell [26]. In addition, an automated syringe attached to
the ﬂow cell is used for buffer exchange and delivering various drugs,
i.e., AmB, Alexa Fluor® 635 phalloidin, QD-EGF, in an optimally con-
trolled manner. Finally, this temperature-controlled microﬂuidic ﬂow
cell is incorporated into microscopy systems. In this study, HT29 cells
were delivered to the ﬂow cell and seeded onto collagen-1-coated
glass coverslips for 3 h at 37 °C. Next the cells were pretreated with
10 μg/ml of TCHE for 21 h at 37 °C. During cell seeding and TCHE pre-
treatment processes, the ﬂow cell was stored in a covered Petri dish
and kept in the incubator at 37 °C and 5% CO2. Finally, the ﬂow cell
was assembled with the ﬂow delivery system; this allowed us conduct
real-time probing the time- and dose-dependence of AmB induced per-
meability changes across ergosterol-containing membranes. Note that,
during experiments the ﬂow cell was carefully sealed and protected to
prevent changes in drug concentration by medium loss.
2.4. Epi-ﬂuorescence imaging
Fluorescence images of cells were obtained with an inverted micro-
scope (TE2000U, Nikon) equipped with an objective lens (Plan Apo
60×/1.40 oil, Nikon), band-pass ﬁlters for QD 565 and Alexa 635, and
an EMCCD camera (LucaEM DL6581, Andor). These images were ac-
quired with a spatial resolution of 112 nm per pixel and with a tempo-
ral resolution of 50 ms.
2.5. Single particle tracking and image analysis
Intracellular microrheology is related to the characterization of the
viscoelastic properties of the cytoplasm of cells [27]. Particle-tracking
microrheology is a powerful technique that allows us to probe the me-
chanical properties of the cytoskeleton in its natural environment.We ap-
plied ourMatlab-based FFT software for cross-correlation processing [26]
to track the lateral displacement of the vesicles within the living cells.
This displacement was then used to determine the two-dimensional
mean square displacement (2-D MSD). For the 2-D random walk, the
2-D MSD increases linearly with time according to the relationship
MSD = 4DΔt, where D and Δt are the diffusion coefﬁcient and time
lag, respectively. Hence, the diffusion coefﬁcient of the vesicles could
be obtained from the linear slope of the MSD plot; values of D could
then be used to probe the effect of AmB ion channels on membrane
permeability and intracellular microrheology. By tracking multiple vesi-
cles within the living cells, particle-tracking microrheology can measure
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of the cell.
3. Results
3.1. Effect of AmB on cell-membrane permeability
We examined the cytotoxicity of combined AmB and TCHE treat-
ment in human colon HT29 cells using an MTT assay (Fig. 1). The data
show that pretreatment with 10 μg/ml TCHE followed by 6 μg/ml
AmBdramatically inhibited the proliferation of HT29 cells. The inhibito-
ry concentration that induced 50% cell viability was further adapted to
conduct the present experiments at the single cell level.
A straightforward approach to characterize the concentration-
dependence of AmB-induced permeability changes across ergosterol-
containing membranes is to use ﬂuorescent dyes of known average
diameter to distinguish the cell-membrane permeability and quantify
the pore size of the AmB ion channels. First, HT29 cells were seeded
onto collagen-1-coated glass coverslips for 3 h at 37 °C. Next, the cells
were pretreated with 10 μg/ml of TCHE for 21 h at 37 °C, followed by
a further incubation with 6 μg/ml AmB for 1 h at 37 °C. To assess mem-
brane permeability, HT29 cells were treated with either 10 nMQD-EGF
at 4 °C for 30 min (Fig. 2) or Alexa Fluor® 635 phalloidin at 37 °C for
30 min (Fig. S2). A large accumulation of QD-EGF (red pseudo-color)
was observed along the periphery of the cell membrane but not in the
cytoplasm for untreated (Fig. 2D) and TCHE-treated HT29 cells in the
absence of AmB (Fig. 2E). However, the cellular distribution of the
QD-EGF ﬂuorescence signal was strongly localized inside the cell in
the presence of AmB (Fig. 2F). Speciﬁcally, pretreatment with TCHE
followed by AmB treatment led to a change in the cell-membrane per-
meability such that the QD-EGF could penetrate the cell membranes
at 4 °C.
To test whether AmB-induced permeability changes were due to
the substitution of cholesterol, the dominant sterol in mammalian cell
membranes, with ergosterol, we further examined membrane perme-
ability of HT29 cells pretreated with either 10 μg/ml pure ergosterol
(Exp. I) or 10 μg/ml TCHE (Exp. II), respectively, to address this question.
Furthermore, HT29 cells pretreated with 10 μg/ml of TCHE for 1 h at
37 °C followed by 6.5 nM AmB for 1 h at 37 °C (Exp. III), together with
HT29 cells treated with 6.5 μM AmB alone for 1 h at 37 °C (Exp. IV),
were performed as control experiments. Finally,membrane permeability
of these four experiments was assessed using Alexa Fluor® 635
phalloidin, as shown in Fig. S3. Here, the bright-ﬁeld cell images of
HT29 cells and the corresponding epi-ﬂuorescence images of theFig. 1. Determination of cell viability byMTT assay. MTT assay was performed to evaluate
HT29 cell cytotoxicity pretreated with the TCHE followed by AmB at different concentra-
tions ranging from 0 to 6 μg/ml.cellular uptake of Alexa Fluor® 635 phalloidin were shown in the
left (A, C, E and G) and right (B, D, F and H) panels, respectively. As
shown in the epi-ﬂuorescence images, Alexa Fluor® 635 phalloidin
can freely penetrate the cell membrane in the cases of Exp. I and II
(B and D). However, in the case of Exp. III, cell membrane permeability
changewas not seenwith shorter TCHE incubation time tested. In addi-
tion, the penetration of Alexa Fluor® 635 phalloidin was not observed
in HT29 cells treated with 6 μg/ml AmB alone (in the case of Exp. IV).
This phenomenon demonstrated that the substitution of cholesterol
with ergosterol has occurred when HT29 cells pretreated with either
pure ergosterol or TCHE for 21 h at 37 °C.
3.2. Quantifying the pore size of the AmB ion channels
In an attempt to quantify whether the pore size of the AmB ion
channels depends on the AmB dose, we applied ﬂuorescent probes
based on Alexa Fluor 635 phalloidin and QD-EGF. The procedures for
cell treatments were similar to those employed to generate Fig. 2,
where HT29 cells were incubated with AmB at four different concentra-
tions ranged from for 1 h at 37 °C: 40 pg/ml, 50 pg/ml, 1 ng/ml, and
2 ng/ml. The corresponding bright-ﬁeld images of HT29 cells are shown
in Fig. 3A–D. Here, HT29 cells were treated with Alexa Fluor® 635
phalloidin at 37 °C for 30 min; this treatment allowed us to determine
the pore size of the AmB ion channels at low AmB concentrations. To
determine the pore size of the AmB ion channels at higher AmB concen-
trations, HT29 cells were treatedwith 10 nMQD-EGF at 4 °C and ﬁxed in
4% PFA. As shown in the epi-ﬂuorescence images, Alexa Fluor® 635
phalloidin cannot freely penetrate the cell membrane at 40 pg/ml AmB
(Fig. 3E), but it can do so at 50 pg/ml (Fig. 3F). This phenomenon implied
that the pore diameter was nearly 16 Åwhen the concentrations of AmB
fellwithin the range of 40–50 pg/ml. Similarly,when theAmBconcentra-
tion was higher than 2 ng/ml, QD-EGF (red pseudo-color) could freely
penetrate the cell membrane, which demonstrated that the pore di-
ameter was nearly 16 nmwhen the concentrations of AmB fell with-
in the range of 1–2 ng/ml (Fig. 3G and H). This observation revealed
that permeability changes across ergosterol-containing membranes
are dependent on the AmB dose. Note that these two simultaneous
ﬂuorescence images of QD-EGF (Fig. 3G and H) were taken using an
inverted epi-ﬂuorescent microscope equipped with an EMCCD camera
at the same image focal plane; however, all two-dimensional optical
slices have an in-focus plane and a contribution from the out-of-focus
ﬂuorescence that obscures the image and reduces contrast. This may ex-
plain why some QDs-EGF were concentrated close to membrane espe-
cially when the pore size of the AmB ion channels was almost the same
as the size of the QD-EGF, as shown in Fig. 3H.
Besides, it is not knownwhether channel or pore formation inﬂuences
EGFR-mediated internalization when the pore diameter is smaller than
the size of QD-EGF (16 nm). The cellular uptake of QD-EGF in HT29
cells at 37 °C (Fig. S4 and Mov. S1) demonstrated that EGFR-mediated
internalization still occurred in the presence of 1 ng/ml AmB, indicating
that EGFR dimerization was not inhibited.
3.3. Effect of AmB on intracellular microrheology
Because we have shown that AmB induces permeability changes
across ergosterol-containing membrane in a concentration depen-
dent manner, the present study also aims to present a real-time cell
membrane permeabilization method for the detection of intracellular
microrheology in the absence and presence of AmB ion channels. In
this study, particle-trackingmicrorheology, as determined bymeasure-
ment of the lateral displacement of the vesicles within the living cells,
was applied to follow the kinetics of the permeability changes that
were induced by the presence of the AmB ion channels. Simultaneous
bright-ﬁeld images of the same living, single HT29 cell pretreated
with 10 μg/ml TCHE for 21 h at 37 °C were captured before (A), (see
also Mov. S2), during (B–D) and after (E) (see also Mov. S3) treatment
Fig. 2. Probing membrane permeability using QD-EGF. First, HT29 cells were seeded onto collagen-1-coated glass coverslips for 3 h at 37 °C. Next the cells were pretreated with
10 μg/ml of TCHE for 21 h at 37 °C. Finally, they were incubated with 6 μg/ml AmB for 1 h at 37 °C. (A–C) The bright-ﬁeld cell images of HT29 cells at these three stages. (D–F)
The epi-ﬂuorescence images of the cellular uptake of QD-EGF corresponding to these three stages.
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mine whether the AmB induced time-dependent permeability changes
across ergosterol-containing membranes.
We then applied particle-tracking microrheology to determine the
lateral displacement of vesicles within living cells. Thus, the transport
velocity, MSD, and diffusion coefﬁcient of a single vesicle could be
obtained at each time point (A through E). The image-processing proce-
dures for this analysis are shown in Fig. 4. For example, six individual
vesicles were arbitrarily selected from the bright-ﬁeld image at time
point E (left), as shown on the upper right of Fig. 5, revealing the lateral
displacements of the vesicles in microdomains. The corresponding
two-dimensional trajectories of each vesicle were also plotted. Below
are twoMSDplots obtained from trajectories of vesicles 1 and 2, respec-
tively, from which the diffusion coefﬁcient of the vesicles could be
obtained by determining the linear slope of the MSD plot.
The average values of both the velocityﬂuctuations and diffusion co-
efﬁcients of vesicles within the living cell at each time point (A through
E) are demonstrated in Fig. 6. The experimental conditions used to ob-
tain Fig. 6 were the same as those for Fig. 4; during the measurements,
more than 140 vesicles at each time point were tracked ofﬂine for 100
frames (5 s) from the same single, living cell. The resultant data show
that increased AmB exposure time resulted in a rapid increase in both
the velocityﬂuctuations (rootmean square velocity) and diffusion coef-
ﬁcients of vesicles within the living cells until a plateau was reached.
This time-dependent increment was caused by the addition of 6 μg/ml
AmB in conjunction with the TCHE pretreatment. In contrast, no varia-
tions occurred with the addition of 6 μg/ml AmB alone (Fig. S5).
As a straightforward measure of observing osmosis at the single cell
level, the real-time changes in the dimensionless cell thickness were
used to characterize whether the AmB-induced osmotic lysis can be
completely prevented by the incubation of HT29 cells into a sucrose-
containing medium. The time-dependence of the dimensionless cellthickness changes across ergosterol-containing membrane was shown
in Fig. S6, where the dimensionless cell thickness was deﬁned as the
ratio of the cell thickness during experiment to cell thickness at the be-
ginning of the AmB ﬂow (time point a). The data showed that pretreat-
ment with 10 μg/ml TCHE followed by 6 μg/ml AmB caused a dramatic
increase in the cell thickness of HT29 cell during timepoints a through c.
The cell thickness reached to itsmaxima after treatmentwith 50 mMsu-
crose for 10 min at 37 °C, and then decreased slightly to ﬁnally remained
constant after time point d. In contrast, cell thicknesses was remained
constant (≅10 μm) when HT29 cells pretreated with 10 μg/ml of TCHE
for 21 h at 37 °C followed by 6.5 nMAmB for 1 h at 37 °C. This phenom-
enonalso suggested that AmB-induced osmotic lysiswas occurreddue to
the presence of larger pore size of the AmB ion channels.
3.4. Geometry model for predicting the pore size of the AmB ion channels
The other main focus of the present study is to present a theoretical
model proposing amechanismbywhich the AmB concentration controls
the diameter of AmB ion channels on the ergosterol-containing mem-
brane. A recent study has found that ergosterol may increase membrane
ﬂuidity more than cholesterol [28]. Thus, we hypothesize that the local
interfacial area expansion induced by increasing AmB concentrations
may be attributed to the preferential accumulation of AmB ion channels.
To test this idea, we applied a two-dimensional semi-regular tessellation
model to analyze and categorize the effects of the AmB molecule con-
centration on the membrane permeability in the presence of excess
membrane-embedded ergosterol. Speciﬁcally, we sought to determine
whether increasing AmB concentration tends to increase the preferen-
tial accumulation of AmB ion channels.
This model predicted that the diameter (Lc) of the AmB ion channels
covered by this semi-regular tessellation, n by n AmB ion channels and
the corresponding number of AmB molecules (nAmB) could be written
Fig. 3. Quantitative estimation of the AmB ion channel pore size. (A–D) The bright-ﬁeld images of HT29 cells in the presence of AmB at concentrations of 40 pg/ml, 50 pg/ml, 1 ng/ml, and
2 ng/ml, respectively. (E, F) and (G, H) The corresponding epi-ﬂuorescence images of the cellular uptake of Alexa Fluor® 635 phalloidin and QD-EGF, respectively.
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where R and L were 8 Å and 3.97 Å, respectively. For example, the eight
subunits (i.e. an annulus of eight AmBmolecules hydrophobically linked
to the eight ergosterol molecules) make up a single AmB ion channel,
whereas values of 24 and 960 subunits make up the 2 by 2 and 15 by
15 preferentially accumulated AmB ion channels, respectively. It follows
that the corresponding values of the AmB ion channel diameters are
8 Å, 19.97 Å, and 17.56 nm for a single AmB ion channel, 2 by 2 accumu-
lated AmB ion channels, and 15 by 15 accumulated AmB ion channels,
respectively (Fig. 7).
4. Discussion
In the present work, the concentration-dependence of AmB-
induced permeability changes across ergosterol-containingmembranes
is characterized using ﬂuorescent dyes of known average diameter atthe single-cell level. We ﬁnd that Alexa Fluor® 635 phalloidin, with a
diameter of nearly 16 Å, and QD-EGF, with a diameter of nearly 16 nm,
can freely penetrate the cell membrane at 50 pg/ml AmB and 2 ng/ml
AmB, respectively. Conversely, Alexa Fluor® 635 phalloidin and QD-EGF
are physically blocked from entering the smaller pores at 40 pg/ml
AmB and 1 ng/ml AmB, respectively. This scenario demonstrates that
the pore size of AmB ion channels depends on the concentration of AmB.
The present work also shows that the pore size of the AmB ion chan-
nels is tunable and has been veriﬁed in the range of 16 Å to 16 nm using
Alexa Fluor® 635 phalloidin and QD-EGF. Note that the sizes of both
Alexa Fluor® 635 phalloidin and QD-EGF are larger than a single AmB
ion channel (8 Å). To quantify the relationship between the pore size of
the AmB ion channels and the corresponding AmB concentration, we ap-
plied a two-dimensional semi-regular tessellation model. This model
predicts the preferential accumulation of the AmB ion channels from a
geometric perspective. We hypothesize that the ﬂuorescent molecules
Fig. 4. Probing the time-dependence of AmB induced permeability changes across ergosterol-containing membranes in real-time. (A–E) The simultaneous bright-ﬁeld live cell imaging
captured before (A), during (B–D) and after (E) treatment with 6 μg/ml AmB for 2.5 h at 37 °C subsequent to pretreatment with 10 μg/ml TCHE for 21 h at 37 °C.
Fig. 5. The effect of AmB-induced membrane permeability on the dynamics of intracellular vesicles within the living cell. On the right, there are six arbitrarily selected individual
vesicles obtained from the bright-ﬁeld image at time point e (left), revealing the lateral displacements of the vesicles in the microdomains. The corresponding two-dimensional
trajectories of each vesicle are also plotted. Below are two MSD plots obtained from trajectories of vesicles 1 and 2, respectively, which can be used to further probe the intracellular
microrheology.
1799T.-S. Yang et al. / Biochimica et Biophysica Acta 1828 (2013) 1794–1801
Fig. 6. Time-dependence of AmB-induced membrane permeability. The average values
of both velocity ﬂuctuations and diffusion coefﬁcients of vesicles within the living cell
at each time point (A through E), revealing the effect of AmB-induced membrane per-
meability on intracellular microrheology.
1800 T.-S. Yang et al. / Biochimica et Biophysica Acta 1828 (2013) 1794–1801can penetrate the cell membrane when they are smaller than the diame-
ter of AmB ion channels. We have determined the lower limit of AmB
concentration (50 pg/ml AmB) that allows Alexa Fluor® 635 phalloidin
to freely penetrate the cell membrane. However, the diameter of Alexa
Fluor® 635 phalloidin is larger than the pore size of a single AmB ion
channel; therefore, AmB ion channels should preferentially accumulate
such that their corresponding diameter is larger than 16 Å. The present
semi-regular tessellation model suggests that the 2 by 2 preferentially
accumulated AmB ion channels fulﬁll this requirement, where Lc and
nAmB are 19.97 Å and 24, respectively. Furthermore, the present model
suggests that the 15 by 15 preferentially accumulated AmB ion channels
allow a tunable AmB ion channel pore size slightly larger than the di-
ameter of QD-EGF, where Lc and nAmB are 17.56 nm and 960, respec-
tively. Therefore, this model requires an AmB concentration of at
least 2 ng/ml—speciﬁcally, 50 pg/ml × (960/24)—such that QD-EGF
can freely penetrate the cell membrane. When the concentration ofFig. 7. Schematic picture of the AmB-induced membrane permeability. This scenario showe
diameters of AmB ion channels as a function of the concentration of amphotericin-B. On the
diameter, where a regular octagon with the distance between two opposite sides (span) is 1
possible inscribed circle that can be drawn interior is 8 Å, namely, the minimum pore diamAmB is 1 ng/ml, the present model predicts that the values of Lc and
nAmB are ≅12 nm and 480, respectively. Consequently, QD-EGF cannot
freely penetrate the cell membrane when the concentration of AmB is
less than 1 ng/ml. These scenarios and the experimental situations
have been validated (Fig. 3G and H). We anticipate that, using this
semi-regular tessellation model, we can properly predict the diameters
of AmB ion channels as a function of the AmB concentration.
Using anMTT cytotoxicity assay, we also determined that the control
group and the HT29 cells pretreated with 10 μg/ml TCHE followed by
1.5 μg/ml AmB do not differ (Fig. 1). However, cytotoxic effects were
observed in HT29 cells pretreated with 10 μg/ml TCHE followed by
treatment with concentrations of AmB greater than or equal to 3 μg/ml
(Fig. 1). Taken together, these ﬁndings suggest that AmB ion channel
formation is not causally linked to cytotoxicity in HT29 cells when the
pore size of the AmB ion channels falls between 8 Å (the pore size of
single AmB ion channel) and 17.56 nm; however, the treatment would
result in the larger pore size of the AmB ion channels that leads to cyto-
toxic effects.
The present work provides additional methods to monitor the
formation of AmB ion channels and to probe their inﬂuence on the tem-
poral response of intracellular microenvironments. It has been noted
that AmB ion channel formationmay alsomediatewater inﬂux; this os-
motic stimulus triggers the mitogen-activated protein kinase (MAPK)
pathways [29]. MAPK also plays a role in the regulation of cytoskeletal
dynamics [30,31]. We used particle-tracking microrheology, together
with our single-cell analysis platform [32], to probe the local mechani-
cal properties within living HT29 cells. This platform allowed us to
visualize the time-dependence of AmB induced permeability changes
across ergosterol-containingmembranes.We found that both the velocity
ﬂuctuations and diffusion coefﬁcients of vesicles increased signiﬁcantly
within the living HT29 cells (Fig. 6). In particular, both the velocity ﬂuctu-
ations and diffusion coefﬁcients of vesicles increases approached 50%
during the earliest stages of treatment (0–30 min) with 6 μg/ml AmB.
This increase was of the same order as the potassium ion efﬂux time
scale caused by AmB [16]. The phenomenon of AmB-induced osmotic
lysis, a dramatic increase in the cell thickness (Fig. S6), was also revealedd the semi-regular tessellation model composed of octagons and squares to predict the
left, a simple geometric model is proposed to describe a single AmB ion channel 8 Å in
1.97 Å, the length of each side of a regular octagon is 4.96 Å, and accordingly the largest
eter of AmB ion channels.
1801T.-S. Yang et al. / Biochimica et Biophysica Acta 1828 (2013) 1794–1801in this study; therefore, MAPK pathways triggered by the formation of
such large AmB ion channels may explain why this osmotic stimulus en-
hance the values of overall velocityﬂuctuations and vesicle diffusion coef-
ﬁcients within the living HT29 cells.
5. Conclusions
This study characterizes the concentration- and time-dependence
of AmB-induced permeability changes across ergosterol-containing
membranes. Our observation reveals that the pore size of the AmB
ion channels is tunable and has been veriﬁed in the range of 16 Å to
16 nm (in the low AmB dose regime), where the diameters of AmB
ion channels as a function of AmB dose can be properly predicted
using a semi-regular tessellation model. However, the formation of
AmB ion channels with a large pore size promotes water inﬂux into
cells and enhances the values of overall velocity ﬂuctuations and vesicle
diffusion coefﬁcients within the living HT29 cells (in the high AmB dose
regime). In addition, the larger the pore size of the AmB ion channels, the
more rapid the water inﬂux into cells leads to cytotoxic effects. We are
currently investigating the relationship between MAPK pathways and
the kinetics of the permeability changes induced by the presence of the
AmB ion channels; these results will be reported in the near future.
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